Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial
Martin Wermke(National Center for Tumor Diseases), Cedrik M. Britten(Johannes Gutenberg University Mainz), Peter Brossart(University Hospital Bonn), Steffen Walter(Universität Ulm), Dejka M. Araujo(The University of Texas MD Anderson Cancer Center), Oliver Schoor(Immatics Biotechnologies (Germany)), Linus Backert(Immatics Biotechnologies (Germany)), M. Alper Kursunel(Immatics Biotechnologies (Germany)), Mamta Kalra, Katrin Wetzko(University Hospital Carl Gustav Carus), Tobias A.W. Holderried(Brigham and Women's Hospital), Regina Mendrzyk(Immatics Biotechnologies (Germany)), Katrin Aslan(Immatics Biotechnologies (Germany)), Silvana Hengler(Immatics Biotechnologies (Germany)), Apostolia M. Tsimberidou(The University of Texas MD Anderson Cancer Center), Jens Hukelmann(Immatics Biotechnologies (Germany)), Winfried Alsdorf(Universität Hamburg), Mohammad B. Hossain, Jason J. Luke(University of Chicago), Harpreet Singh‐Jasuja(Immatics Biotechnologies (Germany)), Sebastian Bunk(Immatics Biotechnologies (Germany)), Claudia Wagner(Immatics Biotechnologies (Germany)), Norbert Hilf(Immatics Biotechnologies (Germany)), Karine Pozo(The University of Texas Southwestern Medical Center), Carsten Bokemeyer(Universität Hamburg), Dominik Maurer(Immatics Biotechnologies (Germany)), Manik Chatterjee(University of Würzburg), Ran Reshef(Abramson Cancer Center), Toni Weinschenk(Immatics Biotechnologies (Germany)), Jens Fritsche(Immatics Biotechnologies (Germany)), Heiko Schuster(Immatics Biotechnologies (Germany)), Hans‐Georg Rammensee(Max Planck Institute for Biology), Andrea Mayer-Mokler(Immatics Biotechnologies (Germany)), Carsten Reinhardt(Immatics Biotechnologies (Germany)), Ali Mohamed, Delfi Krishna, M Letizia(Immatics Biotechnologies (Germany)), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Swapna Gulde(Immatics Biotechnologies (Germany)), Arun Satelli(The University of Texas MD Anderson Cancer Center)
Cited by 5
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
MHC ligands and peptide motifs: first listing
|Immunogenetics|1995|1.6k
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)
|The Lancet Oncology|2008|1.1k
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
|Journal of Clinical Oncology|2018|925